Long-term Small Population Size, Deleterious Variation, and Altitude Adaptation in the Ethiopian Wolf, a Severely Endangered Canid
Molecular Biology and Evolution · 2023
DOI: 10.1093/molbev/msac277 ↗Kurz gefasst
Fachartikel in der Zeitschrift Molecular Biology and Evolution, 2023. Verfasst von Jazlyn A Mooney und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Human Genetics, University of California Los Angeles, Los Angeles, CA 90095, USA. Hauptthemen laut MEDLINE: Wolves, Canidae. Die Arbeit wurde bisher 49-mal zitiert (Crossref) und nennt 100 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: NIGMS NIH HHS.
Abstract (Originalsprache)
Ethiopian wolves, a canid species endemic to the Ethiopian Highlands, have been steadily declining in numbers for decades. Currently, out of 35 extant species, it is now one of the world's most endangered canids. Most conservation efforts have focused on preventing disease, monitoring movements and behavior, and assessing the geographic ranges of sub-populations. Here, we add an essential layer by determining the Ethiopian wolf's demographic and evolutionary history using high-coverage (∼40×) whole-genome sequencing from 10 Ethiopian wolves from the Bale Mountains. We observe exceptionally low diversity and enrichment of weakly deleterious variants in the Ethiopian wolves in comparison with two North American gray wolf populations and four dog breeds. These patterns are consequences of long-term small population size, rather than recent inbreeding. We infer the demographic history of the Ethiopian wolf and find it to be concordant with historic records and previous genetic analyses, suggesting Ethiopian wolves experienced a series of both ancient and recent bottlenecks, resulting in a census population size of fewer than 500 individuals and an estimated effective population size of approximately 100 individuals. Additionally, long-term small population size may have limited the accumulation of strongly deleterious recessive mutations. Finally, as the Ethiopian wolves have inhabited high-altitude areas for thousands of years, we searched for evidence of high-altitude adaptation, finding evidence of positive selection at a transcription factor in a hypoxia-response pathway [CREB-binding protein (CREBBP)]. Our findings are pertinent to continuing conservation efforts and understanding how demography influences the persistence of deleterious variation in small populations.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Human Genetics, University of California Los Angeles, Los Angeles, CA 90095, USA.
- Department of Biology, Stanford University, Stanford, CA, USA.
- Department of Quantitative and Computational Biology, University of Southern California, Los Angeles, CA, USA.
- Department of Ecology & Evolutionary Biology, University of California Los Angeles, Los Angeles, CA, USA.
- Department of Chemistry and Biochemistry, University of California Los Angeles, Los Angeles, CA, USA.
ORCID-Profile: Jazlyn A Mooney
Förderung
- NIGMS NIH HHS
Zitieren
APA
Mooney, J. A., Marsden, C. D., Yohannes, A., Wayne, R. K., & Lohmueller, K. E. (2023). Long-term Small Population Size, Deleterious Variation, and Altitude Adaptation in the Ethiopian Wolf, a Severely Endangered Canid. Molecular Biology and Evolution. https://doi.org/10.1093/molbev/msac277
Vancouver
Mooney JA, Marsden CD, Yohannes A, Wayne RK, Lohmueller KE. Long-term Small Population Size, Deleterious Variation, and Altitude Adaptation in the Ethiopian Wolf, a Severely Endangered Canid. Molecular Biology and Evolution. 2023. doi:10.1093/molbev/msac277
BibTeX
@article{Mooney2023,
author = {Mooney, Jazlyn A and Marsden, Clare D and Yohannes, Abigail and Wayne, Robert K and Lohmueller, Kirk E},
title = {Long-term Small Population Size, Deleterious Variation, and Altitude Adaptation in the Ethiopian Wolf, a Severely Endangered Canid},
journal = {Molecular Biology and Evolution},
year = {2023},
doi = {10.1093/molbev/msac277}
}
EUVIMED